SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
18793832
Source:
http://linkedlifedata.com/resource/pubmed/id/18793832
Search
Subject
(
56
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0001617
,
umls-concept:C0004048
,
umls-concept:C0024117
,
umls-concept:C0030705
,
umls-concept:C0035647
,
umls-concept:C0037369
,
umls-concept:C0684249
pubmed:issue
1
pubmed:dateCreated
2009-1-2
pubmed:abstractText
COPD is associated with an increased risk of lung cancer. We examined whether inhaled corticosteroids (ICS) used concomitantly with long-acting beta(2)-agonists (LABA) were associated with reduction in lung cancer risk in COPD patients.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8908438
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adrenal Cortex Hormones
,
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Agonists
,
http://linkedlifedata.com/resource/pubmed/chemical/Bronchodilator Agents
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1532-3064
pubmed:author
pubmed-author:DavisKourtney JKJ
,
pubmed-author:FabbriLeonardo MLM
,
pubmed-author:KiriVictor AVA
,
pubmed-author:SorianoJoan BJB
pubmed:issnType
Electronic
pubmed:volume
103
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
85-90
pubmed:meshHeading
pubmed-meshheading:18793832-Administration, Inhalation
,
pubmed-meshheading:18793832-Adrenal Cortex Hormones
,
pubmed-meshheading:18793832-Adrenergic beta-Agonists
,
pubmed-meshheading:18793832-Aged
,
pubmed-meshheading:18793832-Aged, 80 and over
,
pubmed-meshheading:18793832-Asthma
,
pubmed-meshheading:18793832-Bronchodilator Agents
,
pubmed-meshheading:18793832-Cardiovascular Diseases
,
pubmed-meshheading:18793832-Case-Control Studies
,
pubmed-meshheading:18793832-Drug Administration Schedule
,
pubmed-meshheading:18793832-Female
,
pubmed-meshheading:18793832-Humans
,
pubmed-meshheading:18793832-Incidence
,
pubmed-meshheading:18793832-Logistic Models
,
pubmed-meshheading:18793832-Lung Neoplasms
,
pubmed-meshheading:18793832-Male
,
pubmed-meshheading:18793832-Mental Disorders
,
pubmed-meshheading:18793832-Middle Aged
,
pubmed-meshheading:18793832-Pulmonary Disease, Chronic Obstructive
,
pubmed-meshheading:18793832-Retrospective Studies
,
pubmed-meshheading:18793832-Risk
,
pubmed-meshheading:18793832-Smoking Cessation
pubmed:year
2009
pubmed:articleTitle
Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking.
pubmed:affiliation
Worldwide Epidemiology, GlaxoSmithKline R&D, Greenford, UK. victor.kiri@parexel.com
pubmed:publicationType
Journal Article
,
Comparative Study